Journal Basic Info
- Impact Factor: 1.809**
- H-Index: 6
- ISSN: 2474-1655
- DOI: 10.25107/2474-1655
Major Scope
- Dentistry and Oral Biology
- Epidemiology
- Obstetrics and Gynecology
- Physiology
- Diabetology
- Depression
- Breast Neoplasms
- Physical Medicine & Rehabilitation
Abstract
Citation: Ann Clin Case Rep. 2019;4(1):1639.DOI: 10.25107/2474-1655.1639
Treatment of a Refractory Angiolipoma with Thoracic Extension
Hsiu-Ping Chou, Yi-Jhih Huang, Kai-Hsiung Ko, Yu-Chun Lin and Tsai-Wang Huang
Department of Surgery, Division of Thoracic Surgery, Tri-Service General Hospital, Taiwan
Department of Radiology, Tri-Service General Hospital, Taiwan
Department of Pathology, Tri-Service General Hospital, Taiwan
*Correspondance to: Tsai-Wang Huang
PDF Full Text Case Report | Open Access
Abstract:
The spinal angiolipoma is a rare disease. It is a benign lesion that composed of angiomatous and lipomatous structure. It can be diagnosed via the magnetic resonance imaging. Spinal cord compression is common and the neurological symptoms may also appear. Surgical resection is the most important treatment that relieved the symptoms. Spinal angiolipoma rarely recurred. However, some residual lesions may cause newly developed neurological symptoms. Adjuvant radiotherapy is a choice after the surgical resection. Most of the patients underwent surgical resection. After the surgical treatment, the neurological deficit in this patients vanished. However, some studies shows treatment of infiltrating angiolipomas is aimed at wide excision with radiotherapy indicated for cases of recurrence. Surgical removal should be followed by closely monitoring with physical examination and image even when the pathologically reported benign tumor. Further radiotherapy may be taken into consideration if this benign tumor has any malignant potential.
Keywords:
Angiolipoma; Tumors; Treatment
Cite the Article:
Chou H-P, Huang Y-J, Ko K-H, Lin Y-C, Huang T-W. Treatment of a Refractory Angiolipoma with Thoracic Extension. Ann Clin Case Rep. 2019; 4: 1639.